These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 30449859

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab].
    Nakano M, Kameyama H, Shimada Y, Hashimoto Y, Hosoi M, Nakano M, Nogami H, Hanyu T, Takizawa K, Ishikawa T, Sakata J, Kobayashi T, Minagawa M, Kosugi S, Koyama Y, Wakai T.
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1785-7. PubMed ID: 25731329
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A, Yamashita K, Tanioka H, Tsuji A, Inukai M, Yamakawa T, Yamatsuji T, Yoshimitsu M, Toyota K, Yamano T, Nagasaka T, Okajima M.
    Drug Des Devel Ther; 2016 Nov; 10():3827-3835. PubMed ID: 27920498
    [Abstract] [Full Text] [Related]

  • 27. Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.
    Godinho J, Casa-Nova M, Mesquita T, Baptista MJ, Araújo F, Vale J, Passos Coelho JL.
    J Oncol Pharm Pract; 2019 Mar; 25(2):497-501. PubMed ID: 29121830
    [Abstract] [Full Text] [Related]

  • 28. A Case of Capecitabine-induced Hyperammonemia in a Patient with Colon Cancer.
    Fang W, Fu Y, Wei J.
    Curr Drug Saf; 2018 Mar; 13(1):55-58. PubMed ID: 28782476
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Two Cases of Stage Ⅳ Colorectal Cancer with Long-Term Survival following Single-Agent Chemotherapy with Capecitabine-A Case Reports].
    Suda K, Chiku T, Fukuyama M, Shinoda K, Hashiba H, Sano W, Ando K.
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1882-1884. PubMed ID: 36733031
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
    Wan Y, Hui H, Wang X, Wu J, Sun S.
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Severe adverse events due to dihydropyrimidine dehydrogenase deficiency in a Japanese patient with colon cancer taking capecitabine: a case report.
    Tsutsui M, Yamamoto S, Yoshikawa Y, Nakanishi R, Takano K, Osumi K, Akatsu T, Yoneyama K, Nakagawa M, Kanai T.
    Int Cancer Conf J; 2018 Oct; 7(4):125-129. PubMed ID: 31149530
    [Abstract] [Full Text] [Related]

  • 36. Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature.
    Zou Y, Liu S, Wu J, Sun Z.
    World J Surg Oncol; 2021 Nov 22; 19(1):332. PubMed ID: 34809643
    [Abstract] [Full Text] [Related]

  • 37. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.
    Nagasaka T, Mishima H, Sawaki A, Shimokawa M, Inukai M, Shinozaki K, Tanioka H, Nasu J, Nishina T, Hazama S, Okajima M, Yamaguchi Y.
    BMJ Open; 2016 Jun 02; 6(6):e011454. PubMed ID: 27256093
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
    Hong YS, Park YS, Lim HY, Lee J, Kim TW, Kim KP, Kim SY, Baek JY, Kim JH, Lee KW, Chung IJ, Cho SH, Lee KH, Shin SJ, Kang HJ, Shin DB, Jo SJ, Lee JW.
    Lancet Oncol; 2012 Nov 02; 13(11):1125-32. PubMed ID: 23062232
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.